7th Immunotherapy of Cancer Conference

ITOC7 - April 2 - 4, 2020 | Munich, Germany

About ITOC

The 7th Immunotherapy of Cancer Conference (ITOC7) to be held in Munich, Germany from April 2 – 4, 2020 is a European meeting providing a global platform for translational research in the field of immuno-oncology as well as a forum for discussion of early clinical translation and to address its unique challenges.

ITOC7 is organised by the WMA GmbH  in scientific cooperation with the ITOC Association, the Tumor Centre in Munich (TZM), the Society for Immunotherapy of Cancer (SITC), the German Cancer Consortium (DKTK) as well as the Comprehensive Cancer Center Munich (CCCM) in Munich.

The main goal of the series of ITOC conferences is to provide a unique platform for discussions where all those dedicated to the immunotherapy of cancer can exchange their knowledge and latest findings to advance the oncology drug development and delivery.

ITOC7 Committees

 ITOC7 Conference Presidents 

• Mario Sznol
  (Yale School of Medicine, New Haven, CT, United States)

• Michael von Bergwelt
  (LMU, CCC, DKTK, Munich, Germany)

ITOC7 Chairmen of the Scientific Committee 

• Volkmar Nuessler
  (TZM, Munich, Germany)

• Paolo Ascierto
  (Instituto Nazionale Tumori, Italy)

 ITOC7 Scientific Committee 

• Michael Bergmann
  (Medical University Vienna, Austria)

• Christian Blank
  (NKI, Netherlands)

• Lisa Butterfield
  (Parker Institute for Cancer Immunotherapy, United States)

• Tanja de Gruijl
  (Cancer Center Amsterdam, Amsterdam, The Netherlands)

• Samir N. Khleif
  (Georgetown University Medical Center, United States)

• Sebastian Kobold
  (Ludwig-Maximilians-Universität, Germany)

• Zihai Li
  (Ohio State University, Columbus, OH, USA)

• Pedro J. Romero
  (University of Lausanne, Switzerland)

• José Saro
  (Avacta Life Sciences, United Kingdom)

• Barbara Seliger
  (Martin Luther University Halle-Wittenberg, Germany)

• Wenru Song
  (Kira Pharmaceuticals, United States)

• Eric Tartour
  (Hôpital Européen Georges-Pompidou, France)

• Giorgio Trinchieri
  (Center for Cancer Research/NCI/NIH, USA)

• Lei Zheng
  (Johns Hopkins University, Baltimore, MD)

• Christoph Zielinski
  (Medical University of Vienna, Austria)​
   

Please click here to see an overview of the potential conflicts of interest of the scientific committee.

Registration & Information

Important Dates

Abstract Submission Deadline Extended:      December 8, 2019 

Early Bird Registration Deadline:                   December 1, 2019

Deadline for Pre-registration:                        March 10, 2020

Contacts